Repeat the Booster Dose Immediately
If a 15-month-old child barely received a booster shot due to movement during administration, the dose must be repeated immediately during the same visit, or as soon as the child can return to the clinic. 1
Why This Dose Must Be Repeated
- Administering less than the full recommended volume results in inadequate protection against vaccine-preventable diseases. 1
- The incomplete dose should not be counted as valid in the child's immunization record. 1
- The child should be revaccinated according to age-appropriate schedules, treating this as if the dose was never given. 1
Immediate Action Steps
- If the error is discovered while the child is still in the office, administer a complete repeat dose at full volume during the same visit. 1
- If measuring the exact remaining volume is challenging, give a full repeat dose rather than attempting to calculate partial volumes. 1
- If the error is discovered after the child has left, schedule the child to return as soon as possible for a complete dose. 1
Safety Considerations
- The primary concern with vaccine administration errors is inadequate disease protection, not safety from re-administration. 1
- Repeating the dose poses minimal risk and is the standard approach to ensure adequate immunization. 1
Documentation Requirements
- Do not count the incomplete dose in the vaccination record. 1
- Document the incident and the corrective action taken (repeat dose administered). 1
- Ensure proper injection technique for the repeat dose, considering having an assistant gently stabilize the injection site to prevent recurrence. 1
Critical Context for Booster Doses at 15 Months
- The booster dose of Hib or pneumococcal conjugate vaccines at 12-15 months is critical for boosting antibody titers and ensuring continued protection. 2
- These booster doses should be administered at least 8 weeks after the most recent vaccination in the primary series. 2
- Any monovalent or combination Hib conjugate vaccine is acceptable for the booster dose, regardless of the product used for the primary series. 2
Common Pitfall to Avoid
Split doses or reduced volumes have not been adequately studied for serologic response or clinical efficacy, and such practices are explicitly not endorsed by ACIP. 1 Never attempt to "make up" the remaining volume at a later date—always give a full repeat dose.